Results 51 to 60 of about 67,015 (304)

DYNAMICS OF CARDIOVASCULAR SYSTEM PARAMETERS ON A BACKGROUND OF APPLICATION OF ADRENERGIC BLOCKERS IN CHILDREN WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

Педиатрическая фармакология, 2007
The article is dedicated to the issue of curing children with obstructive form of hypertrophic cardiomyopathy. It presents a complex evaluation of adrenergic blockers influence on the clinical finding, heart rate disorder and vegetative regulation of ...
E.A. Tikhomirova, O.O. Kupriyanova, E.N. Basargina, A.P. Ivanov   +3 more
doaj   +2 more sources

Cardiotoxicity with vascular endothelial growth factor inhibitor therapy [PDF]

, 2018
Angiogenesis inhibitors targeting the vascular endothelial growth factor (VEGF) signaling pathway (VSP) have been important additions in the therapy of various cancers, especially renal cell carcinoma and colorectal cancer.
Herrmann, Joerg, Touyz, Rhian M.
core   +2 more sources

Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study

Circulation Cardiovascular Imaging, 2022
Background: In the randomized phase 3 VALOR-HCM study (A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Who Are Eligible for Septal Reduction Therapy) of patients with obstructive hypertrophic ...
P. Cremer, J. Geske, A. Owens, W. Jaber, S. Harb, S. Saberi, Andrew Wang, M. Sherrid, S. Naidu, H. Schaff, N. Smedira, Qiuqing Wang, K. Wolski, K. Lampl, A. Sehnert, S. Nissen, M. Desai   +16 more
semanticscholar   +1 more source

Molecular analysis of sarcomeric and non-sarcomeric genes in patients with hypertrophic cardiomyopathy. [PDF]

, 2015
Background: Hypertrophic cardiomyopathy (HCM) is a common genetic heart disorder characterized by unexplained left ventricle hypertrophy associated with non-dilated ventricular chambers.
BOTTILLO, IRENE, CAPUTO, VIVIANA, Castori, M, D'ANGELANTONIO, DANIELA, De Bernardo, C, Giannarelli, D, GRAMMATICO, Paola, LIPARI, MARTINA, Majore, S, PAIARDINI, ALESSANDRO, PIZZUTI, Antonio, Re, F, Zachara, E   +12 more
core   +1 more source

Acute myocardial infarction occurring after hypertrophic obstructive cardiomyopathy with paroxysmal atrial fibrillation: a case report

Journal of International Medical Research, 2022
Atheromatous plaque rupture and coronary artery stenosis/occlusion are leading causes of acute myocardial infarction (AMI). Other reasons for AMI are frequently overlooked.
Dingfeng Fang, Jiabin Xu, Bo Bai, Haibo Chen   +3 more
doaj   +1 more source

Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free wall): a follow-up study using CMR tissue tagging and 3D strain analysis [PDF]

, 2006
Aims: Alcohol septal ablation (ASA) has been successful in the treatment of symptomatic hypertrophic obstructive cardiomyopathy (HOCM). The aim of this study is to evaluate the effects of ethanol-induced myocardial infarcts on regional myocardial ...
Beek, A.M., Dockum, W.G. van, Gotte, M.J.W., Kuijper, J.P., Marcus, J.T., Rossum, A.C. van, Ten Berg, J.M., Ten Cate, F.J., Twisk, J.W., Visser, C.A.   +9 more
core   +2 more sources

Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy

European Heart Journal
Background and Aims Long-term safety and efficacy of mavacamten in patients with obstructive hypertrophic cardiomyopathy (HCM) are unknown. MAVA-LTE (NCT03723655) is an ongoing, 5-year, open-label extension study designed to evaluate the long-term ...
Pablo García-Pavía, A. Oręziak, A. Masri, R. Barriales-Villa, T. Abraham, A. Owens, M. Jensen, Wojciech Wojakowski, Tim Seidler, A. Hagège, N. Lakdawala, Andrew Wang, M. Wheeler, L. Choudhury, G. Balaratnam, A. Shah, S. Fox, S. M. Hegde, I. Olivotto   +18 more
semanticscholar   +1 more source

Myocardial bridge in a child without hypertrophic cardiomyopathy: A case report

Asian Journal of Medical Sciences, 2015
In children, myocardial bridge is an inborn coronary anomaly and is usually found in the patients with hypertrophic cardiomyopathy or left ventricular hypertrophy.
Shiv Kumar Yadav
doaj   +1 more source

Case report: Double-chambered right ventricle diagnosed in a middle-aged female with hypertrophic cardiomyopathy and atrial flutter: A rare case

Frontiers in Cardiovascular Medicine, 2022
Double-chambered right ventricle (DCRV) is a rare congenital heart defect in adults, manifesting with progressive right ventricular outflow tract obstruction.
Junye Ge, Tong Hu, Yan Liu, Qian Wang, Guanqi Fan, Chuanzhen Liu, Jun Zhang, Shiming Chen, Kellina Maduray, Yun Zhang, Tongshuai Chen, Jingquan Zhong, Jingquan Zhong   +12 more
doaj   +1 more source

Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy. [PDF]

, 2017
No ...
Ashley, E, Finocchiaro, G, Magavern, E, Olivotto, I, Papadakis, M, Sharma, S, Sinagra, G, Tome-Esteban, M   +7 more
core   +2 more sources